Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2023-02-14 4:58 pm Purchase | 2022-12-31 | 13G | ALPINE IMMUNE SCIENCES INC ALPN | Paradigm BioCapital Advisors LP | 2,317,634 5.050% | 102,912 (+4.65%) | Filing History |
| 2023-02-14 4:55 pm Purchase | 2022-12-31 | 13G | VOR BIOPHARMA INC.COM VOR | Paradigm BioCapital Advisors LP | 323,900 9.900% | 207,475 (+178.20%) | Filing History |
| 2022-10-27 4:47 pm Purchase | 2022-10-17 | 13G | VOR BIOPHARMA INC.COM VOR | Paradigm BioCapital Advisors LP | 116,425 6.100% | 116,425 (New Position) | Filing History |
| 2022-10-03 5:16 pm Purchase | 2022-09-23 | 13G | ALPINE IMMUNE SCIENCES INC ALPN | Paradigm BioCapital Advisors LP | 2,214,722 5.030% | 2,214,722 (New Position) | Filing History |
| 2022-07-18 4:24 pm Purchase | 2022-07-07 | 13G | OYSTER PT PHARMA INC OYST | Paradigm BioCapital Advisors LP | 1,462,576 5.500% | 1,462,576 (New Position) | Filing History |
| 2022-02-14 06:12 am Purchase | 2021-12-31 | 13G | VIRIDIAN THERAPEUTICS INC VRDN | Paradigm BioCapital Advisors LP | 1,209,051 5.570% | 1,209,051 (New Position) | Filing History |